|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 221 CHF | +0.98% |
|
-0.50% | -9.61% |
| 02:32pm | Roche: positive CHMP opinion for Alecensa | CF |
| 01:58pm | Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU | MT |
Oct 22 (Reuters) - The U.S. Food and Drug Administration on Friday approved Roche Holding AG's eye implant for a chronic disorder causing blurred vision, most patients of which currently have to receive monthly eye injections.
(Reporting by Amruta Khandekar and Bhanvi Satija; Editing by Aditya Soni)
| 1st Jan change | Capi. | |
|---|---|---|
| -9.61% | 193B | |
| +26.08% | 653B | |
| +26.67% | 556B | |
| -6.55% | 354B | |
| +20.38% | 331B | |
| +3.82% | 296B | |
| +12.85% | 233B | |
| +5.63% | 201B | |
| -6.32% | 144B | |
| -11.97% | 143B |
ROCHE HOLDING AG 
